Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-26 @ 4:12 AM
NCT ID:
NCT02229227
Group ID:
EG000
Title:
Albiglutide + Insulin Glargine
Description:
During standardization period, participants transitioned from basal bolus regimen received during screening period to insulin glargine plus insulin lispro. Eligible participants received Albiglutide 30 mg weekly SC injection during the treatment period and insulin lispro dose was down-titrated to half that used in the standardization period. At Week 4, Albiglutide was up-titrated to 50 mg weekly SC injection and insulin lispro was stopped for the remainder of the treatment period.
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
23
Serious Number At Risk:
400
Other Number Affected:
114
Other Number At Risk:
400
Study:
NCT02229227
Results Section:
NCT02229227
Adverse Events Module:
NCT02229227